SIREN : 399293323
MYLAN GENERICS FRANCE HOLDING is a French company founded 31 years ago, specialized in the sector Activités des sièges sociaux. Based in LYON (69007), this company of category GE shows in 2019 a revenue of 1.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | 1 018 679 € | 979 707 € | 872 873 € | 769 769 € |
| Net income | 14 720 895 € | -39 802 € | 13 823 820 € | 17 779 158 € | 40 607 771 € | 41 057 149 € | 41 424 915 € | 41 335 348 € | 41 278 569 € |
| EBITDA | -22 009 € | -49 603 € | -61 544 € | -50 868 € | -58 086 € | 905 728 € | 933 569 € | 787 791 € | 722 886 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | 4030.4% | 4228.3% | 4735.6% | 5362.5% |
In 2024, MYLAN GENERICS FRANCE HOLDING generates positive net income of 14.7 M€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 41.3 M€ -> 14.7 M€.
-22 009 €
-22 009 €
14 720 895 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 86%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.0%
86.088%
0.0
In 2024, the debt ratio of MYLAN GENERICS FRANCE HOL... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of MYLAN GENERICS FRANCE HOL... (86.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of MYLAN GENERICS FRANCE HOL... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 8.37. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
8.371
0.0
In 2024, the liquidity ratio of MYLAN GENERICS FRANCE HOL... (8.37) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of MYLAN GENERICS FRANCE HOL... (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 450 days. Excellent situation: suppliers finance 450 days of the operating cycle (retail model).
0 €
0 j
450 j
0 j
Based on 103 transactions of similar company sales in 2024, the value of MYLAN GENERICS FRANCE HOLDING is estimated at 139 965 080 € (range 48 058 868€ - 376 882 107€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MYLAN GENERICS FRANCE HOLDING with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of MYLAN GENERICS FRANCE HOLDING in 2019 is 1.0 M€.
Yes, MYLAN GENERICS FRANCE HOLDING generated a net profit of 14.7 M€ in 2024.
The headquarters of MYLAN GENERICS FRANCE HOLDING is located in LYON (69007), in the department Rhone.
The tax return of MYLAN GENERICS FRANCE HOLDING is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MYLAN GENERICS FRANCE HOLDING operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.